Executive Board
The Executive Board has been established to assist the Chief Executive in leading The Institute of Cancer Research to achieve its strategic aims and objectives within the approved strategies and budgets and is responsible for formulating strategies, plans and budgets for approval by the Board of Trustees.
Professor Kristian Helin
Chief Executive and President
Carol Ford
Chief People Officer
Professor Kevin Harrington
Head of Division – Radiotherapy and Imaging
Professor Clare Isacke
Dean of Academic & Research Affairs
Paul Norris
Chief Financial Officer
Professor Jonathon Pines
Head of Division – Cancer Biology
Dr Barbara Pittam
Chief Research and Academic Officer
Dr Olivia Rossanese
Head of Division and Director – Cancer Therapeutics
Latest ICR News
Genetic testing for Lynch Syndrome prevents cancers being missed
Genetic testing to identify women with Lynch Syndrome is likely to need to increase dramatically to ensure that carriers are not missed, a new analysis by ICR researchers has found.
MRI scanning and biopsy could reduce delays in the correct treatment for bladder cancer by more than six weeks
Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be used to reduce the time patients wait.
Researchers identify two genes responsible for tumour progression in early-stage prostate cancer
An innovative study has uncovered two genes that promote the formation of prostate tumours.
New drug hope for prostate cancer patients
Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in the journal Clinical Cancer Research.